Device Repurposing in Research
How adapting existing tools can drive innovation
In this episode of Bio Break, Nick Allan and Nigel Syrotuck discuss device repurposing in research, sharing a story that blends microbiology, animal science, and engineering ingenuity. The episode begins with Nick examining an unusual medical device originally used for equine reproductive sampling. As Nigel jokes about its “unique” application, Nick explains how his team repurposed the tool to study bovine respiratory diseases during the COVID era.
The conversation highlights how adaptability is key in research. During supply shortages, Nick’s team used what they had—an equine sampling instrument—to collect deep nasal swabs from cattle for studying Mycoplasma bovis. This creative approach reflects the practical side of device repurposing in research: using proven, sterile, and available tools to advance science quickly and safely.
From animal care to microbiology
Nigel and Nick explore how one device can serve multiple disciplines when handled thoughtfully. Engineers often design instruments for a single, specific purpose. However, researchers in both human and veterinary medicine sometimes find safe, responsible ways to apply existing devices in new contexts. This not only saves time and cost but also helps teams continue important studies despite logistical barriers.
Engineering meets resourcefulness
As Nigel points out, clinicians and engineers must sometimes foresee off-label uses or modifications. Understanding these adaptations helps teams ensure safety while maintaining design integrity. The story reminds us that innovation doesn’t always start from scratch—sometimes it comes from seeing familiar tools in a new way.
By the end, both hosts emphasize that flexibility and informed adaptation can lead to new discoveries, whether in animal health or medical device design.
Enjoying Bio Break? Sign up to get new episodes sent to your inbox.
Related Resources
Jason McGee explores how the Rightness Trap Medtech dynamic can quietly erode enterprise value in medical device companies.
Understanding gram positive vs negative bacteria is essential when studying sterility, microbiology, and antibiotic effectiveness. While many people think the difference is only about staining, the reality is much deeper.
Nick and Nigel explore the science behind hand sanitizer formulations. They discuss how alcohol interacts with bacterial cells, why water improves its effectiveness, and what the additional ingredients in sanitizer actually do.
Scott Phillips, CEO of StarFish Medical, sits down with Peter van der Velden, Managing General Partner at Lumira Ventures, to explore the strategic thinking behind major MedTech transactions and investments.